Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02384031 : Post-dural Puncture Headache - Needles and Biomarkers in CSF
PhaseN/A
AgesMin: 18 Years Max: 60 Years
Eligibility
Inclusion Criteria:

1. Patients at Department of Neurology, Nordland Hospital Trust in Bodø, scheduled for
diagnostic LP

Exclusion Criteria:

1. Dementia

2. Non-compliance or coma

3. Local skin infections over proposed puncture site

4. Suspicion of raised intracranial pressure due to neurological or radiological
findings

5. Bleeding diathesis (thrombocytopenia <50 x 109/L) or ongoing anticoagulant therapy

6. Major spinal column deformities

7. Procedural complications whereby needle type or size change is a requisite

8. Recent LP (< 7 days)
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02384031      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740